Supriya Lifescience Ltd (SUPRIYA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1003587, "name": "Supriya Lifesci.", "stock_name": "Supriya Lifesci.", "full_name": "Supriya Lifescience Ltd", "name_url": "stocks-analysis/supriya-lifesci", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "962.45", "chg": -38.35, "chgp": "-3.83%", "dir": -1, "prev_price": "1,000.80", "mcapval": "7,986.00 Cr", "mcap": "Small Cap", "scripcode": 543434, "symbol": "SUPRIYA", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE07RO01027", "curr_date": "Sep 24, 03:30 PM", "curr_time": "03:55 AM", "last_traded_at": "Sep 24, 03:30 PM IST", "bse_nse_vol": "2.63 lacs", "exc_status": "Active", "traded_date": "Sep 24, 2026", "traded_date_str": "2026 09 24", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/supriya-lifesci-1003587-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Supriya Lifescience Ltd Technical Momentum Shifts Signal Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-ltd-technical-momentum-shifts-signal-bullish-outlook-4202973", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SupriyaLifescie_technicaldot_4202973.png", "date": "2026-09-24 08:04:24", "description": "Supriya Lifescience Ltd has demonstrated a marked shift in price momentum, supported by a series of bullish technical indicators that have upgraded its outlook from a previous sell rating to a hold. The pharmaceutical and biotechnology small-cap stock has surged 6.81% in a single day, reflecting renewed investor confidence and a positive technical trend reversal." }, { "title": "Supriya Lifescience Ltd Surges 7.1% to Day's High of Rs 1003.95 — Outperforms Sector by 6.78 Percentage Points", "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-ltd-hits-intraday-high-with-71-surge-on-23-sep-2026-4202408", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SupriyaLifescie_priceRelatedfactors_4202408.png", "date": "2026-09-23 10:16:43", "description": "The Sensex inched up 0.16% on 23 Sep 2026, but Supriya Lifescience Ltd outpaced the broader market with a robust 7.1% gain, reaching an intraday high of Rs 1003.95. This 6.78 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a market-wide lift." }, { "title": "Supriya Lifescience Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/supriya-lifescience-ltd-is-rated-hold-by-marketsmojo-4202317", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SupriyaLifescie_mojoScore_4202317.png", "date": "2026-09-23 10:10:46", "description": "Supriya Lifescience Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 31 August 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 23 September 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Supriya Lifescience Gains 5.69%: 2 Key Factors Driving the Move", "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-gains-569-2-key-factors-driving-the-move-4191209", "imagepath": "", "date": "2026-09-12 11:02:01", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>7 Sep:</strong> Intraday high surge to Rs.891.60 (+7.72%)</p>\n <p><strong>8 Sep:</strong> Valuation shifts to very expensive with Mojo Grade upgraded to Hold</p>\n <p><strong>11 Sep:</strong> Week closes at Rs.903.85 (-1.62% on day)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.855.20</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.903.85</div><div class=\"stat-change positive\">+5.69%</div></div>\n <div class=\"stat-item\"><div ..." }, { "title": "Supriya Lifescience Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/supriya-lifescience-ltd-is-rated-hold-4191037", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SupriyaLifescie_mojoScore_4191037.png", "date": "2026-09-12 10:10:26", "description": "Supriya Lifescience Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 31 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Supriya Lifescience Ltd Valuation Shifts Signal Changing Market Sentiment", "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-ltd-valuation-shifts-signal-changing-market-sentiment-4185491", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SupriyaLifescie_valuationdot_4185491.png", "date": "2026-09-08 08:01:15", "description": "Supriya Lifescience Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a very expensive rating, even as its stock price surged by 6.45% on 8 Sep 2026. This change reflects evolving market perceptions amid robust returns that have outpaced the broader Sensex over multiple time horizons." }, { "title": "Supriya Lifescience Ltd Surges 7.72% to Day's High of Rs 891.6 — Outperforms Sector by 4.25 Percentage Points", "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-ltd-hits-intraday-high-with-772-surge-on-7-sep-2026-4184334", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SupriyaLifescie_priceRelatedfactors_4184334.png", "date": "2026-09-07 09:33:00", "description": "The Sensex declined 0.26% on 7 Sep 2026, while Supriya Lifescience Ltd surged 7.72%, marking a 4.25 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector. This strong single-session gain stands out amid a broadly weak market backdrop, signalling a stock-specific momentum shift rather than a general market rally." }, { "title": "Supriya Lifescience Gains 6.40%: Technical Momentum and Mixed Financials Shape the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-gains-640-technical-momentum-and-mixed-financials-shape-the-week-4183386", "imagepath": "", "date": "2026-09-05 12:00:48", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>31 Aug:</strong> Technical momentum shifts amid mixed indicator signals</p>\n <p><strong>1 Sep:</strong> Upgraded to Hold as technicals improve despite mixed financials</p>\n <p><strong>4 Sep:</strong> Week closes at Rs.855.20, up 6.40% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.799.40</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.855.20</div><div class=\"stat-change positive\">+6.40%</div></div>\n <div class=\"..." }, { "title": "Supriya Lifescience Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financials", "link": "https://www.marketsmojo.com/news/stock-recommendation/supriya-lifescience-ltd-upgraded-to-hold-as-technicals-improve-amid-mixed-financials-4177231", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SupriyaLifescie_mojoScore_4177231.png", "date": "2026-09-01 08:57:08", "description": "Supriya Lifescience Ltd has seen its investment rating upgraded from Sell to Hold as of 31 August 2026, reflecting a nuanced improvement across technical indicators, valuation metrics, financial trends, and quality parameters. Despite recent quarterly setbacks, the company’s strong management efficiency, net-debt-free status, and growing institutional participation have contributed to a more balanced outlook for investors." } ], "total": 392, "sid": "1003587", "stock_news_url": "https://www.marketsmojo.com/news/supriya-lifescience-1003587" }, "announcements": [ { "caption": "Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015.", "datetime": "23-Sep-2026", "details": "Enclosed herewith is the announcement under Regulation 30 of SEBI (LODR) 2015.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "20-Sep-2026", "details": "Intimation of Analyst/Investor Meeting is enclosed.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "11-Sep-2026", "details": "Intimation of Investor/ Analyst Call is enclosed herewith.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Supriya Lifescience Ltd has declared <strong>50%</strong> dividend, ex-date: 04 Sep 26", "dt": "2026-09-04", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

7 Sep: Intraday high surge to Rs.891.60 (+7.72%)

8 Sep: Valuation shifts to very expensive with Mojo Grade upgraded to Hold

11 Sep: Week closes at Rs.903.85 (-1.62% on day)

Read full news article

Supriya Lifescience Ltd is Rated Hold

2026-09-12 10:10:26

Supriya Lifescience Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 31 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Supriya Lifescience Ltd Valuation Shifts Signal Changing Market Sentiment

2026-09-08 08:01:15

Supriya Lifescience Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a very expensive rating, even as its stock price surged by 6.45% on 8 Sep 2026. This change reflects evolving market perceptions amid robust returns that have outpaced the broader Sensex over multiple time horizons.

Read full news article

Supriya Lifescience Ltd Surges 7.72% to Day's High of Rs 891.6 — Outperforms Sector by 4.25 Percentage Points

2026-09-07 09:33:00

The Sensex declined 0.26% on 7 Sep 2026, while Supriya Lifescience Ltd surged 7.72%, marking a 4.25 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector. This strong single-session gain stands out amid a broadly weak market backdrop, signalling a stock-specific momentum shift rather than a general market rally.

Read full news article

Supriya Lifescience Gains 6.40%: Technical Momentum and Mixed Financials Shape the Week

2026-09-05 12:00:48

Key Events This Week

31 Aug: Technical momentum shifts amid mixed indicator signals

1 Sep: Upgraded to Hold as technicals improve despite mixed financials

4 Sep: Week closes at Rs.855.20, up 6.40% for the week

Read full news article

Supriya Lifescience Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financials

2026-09-01 08:57:08

Supriya Lifescience Ltd has seen its investment rating upgraded from Sell to Hold as of 31 August 2026, reflecting a nuanced improvement across technical indicators, valuation metrics, financial trends, and quality parameters. Despite recent quarterly setbacks, the company’s strong management efficiency, net-debt-free status, and growing institutional participation have contributed to a more balanced outlook for investors.

Read full news article

View All News